Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · IEX Real-Time Price · USD
1.630
0.00 (0.00%)
Mar 28, 2024, 3:39 PM EDT - Market closed

Unity Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20222021202020192018
Market Capitalization
273984277331688
Market Cap Growth
--53.86%-69.60%-16.29%-51.87%-
Enterprise Value
6-948239202516
PE Ratio
-0.67-0.65-1.39-2.95-4.03-9.01
PS Ratio
-164.7817.62---
PB Ratio
0.760.581.423.352.744.28
P/FCF Ratio
-0.88-0.77-1.86-3.51-4.48-11.89
P/OCF Ratio
-0.88-0.76-1.87-3.54-4.57-12.15
EV/Sales Ratio
--36.2310.07---
EV/EBITDA Ratio
-0.280.16-0.88-2.68-2.54-6.96
EV/EBIT Ratio
-0.280.15-0.84-2.58-2.46-6.76
EV/FCF Ratio
-0.340.17-1.06-3.02-2.73-8.92
Debt / Equity Ratio
0.670.710.880.71--
Debt / EBITDA Ratio
-0.51-0.87-0.96-0.66--
Debt / FCF Ratio
-0.61-0.93-1.16-0.75--
Quick Ratio
5.324.835.336.767.4910.35
Current Ratio
5.744.925.456.977.5210.43
Asset Turnover
00.000.04000
Interest Coverage
-14.27-15.84-18.11-71.63--
Return on Equity (ROE)
-99.50%-101.60%-92.30%-94.20%-64.60%-70.00%
Return on Assets (ROA)
-51.40%-50.90%-45.40%-57.40%-54.10%-41.90%
Return on Capital (ROIC)
-84.87%-50.41%-50.55%-66.22%-74.27%-49.45%
Earnings Yield
-191.99%-154.11%-72.05%-33.85%-24.81%-11.10%
FCF Yield
-145.54%-130.50%-53.70%-28.49%-22.34%-8.41%
Buyback Yield / Dilution
-44.94%-70.10%-9.73%-16.60%-54.32%-784.12%
Total Shareholder Return
-44.94%-70.10%-9.73%-16.60%-54.32%-784.12%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).